# A Study to Assess the Safety, Tolerability and Effect of Nexagon™ Applied to the Eye After PRK Laser Eye Surgery for Nearsightedness

> **NCT00654550** · PHASE1 · COMPLETED · sponsor: **OcuNexus Therapeutics, Inc.** · enrollment: 24 (estimated)

## Conditions studied

- Corneal re-Epithelialization

## Interventions

- **DRUG:** Nexagon™ or Nexagon™ vehicle

## Key facts

- **NCT ID:** NCT00654550
- **Lead sponsor:** OcuNexus Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04
- **Primary completion:** 2008-09
- **Final completion:** 2008-12
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2009-01-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00654550

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00654550, "A Study to Assess the Safety, Tolerability and Effect of Nexagon™ Applied to the Eye After PRK Laser Eye Surgery for Nearsightedness". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00654550. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*